Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

Kumar A, Jerzak KJ, Gelmon KA, Boileau JF, Bouganim N, Brezden-Masley C, Cao JQ, Cescon DW, Chia S, Edwards S, Joy AA, Laing K, LeVasseur N, Sehdev S, Simmons C, Webster M, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada

Open source

DOI: 10.3390/curroncol33040200
Published: 2026 Mar 31
Container: Current oncology (Toronto, Ont.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33040200,
  title = {Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).},
  author = {Kumar A and Jerzak KJ and Gelmon KA and Boileau JF and Bouganim N and Brezden-Masley C and Cao JQ and Cescon DW and Chia S and Edwards S and Joy AA and Laing K and LeVasseur N and Sehdev S and Simmons C and Webster M and Manna M and On Behalf Of Patient Advocacy Breast Cancer Canada},
  year = {2026},
  journal = {Current oncology (Toronto, Ont.)},
  doi = {10.3390/curroncol33040200},
  url = {https://doi.org/10.3390/curroncol33040200}
}

RIS

TY  - JOUR
TI  - Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).
AU  - Kumar A
AU  - Jerzak KJ
AU  - Gelmon KA
AU  - Boileau JF
AU  - Bouganim N
AU  - Brezden-Masley C
AU  - Cao JQ
AU  - Cescon DW
AU  - Chia S
AU  - Edwards S
AU  - Joy AA
AU  - Laing K
AU  - LeVasseur N
AU  - Sehdev S
AU  - Simmons C
AU  - Webster M
AU  - Manna M
AU  - On Behalf Of Patient Advocacy Breast Cancer Canada
PY  - 2026
JO  - Current oncology (Toronto, Ont.)
DO  - 10.3390/curroncol33040200
UR  - https://doi.org/10.3390/curroncol33040200
ER  -

APA

A, K., KJ, J., KA, G., JF, B., N, B., C, B., JQ, C., DW, C., S, C., S, E., AA, J., K, L., N, L., S, S., C, S., M, W., M, M., & Canada, O. B. O. P. A. B. C. (2026). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol33040200

Source records

pubmed · retrieved 2026-09-26T15:51:33.308Z